Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India.

Abstract

Background: Plasma neurodegenerative biomarkers are a potential low-cost tool for studying Alzheimer's disease and dementia in population-based research, especially in low- and middle-income countries (LMIC). However, their associations with modifiable risk factors and utility as an outcome in epidemiologic studies remain unclear.

Objective: Our objective was to estimate the cross-sectional association between modifiable lifecourse risk factors for dementia and plasma-based neurodegenerative biomarkers, and to compare those with the associations between lifecourse risk factors and cognition in a population-representative Indian sample.

Methods: Using nationally representative data from the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (N=1625, average age 68.2 years), we estimated linear regressions to compare cross-sectional associations between lifecourse risk factors and both neurodegenerative biomarkers (β-amyloid 42/40, total-tau, phosphorylated Tau181, GFAP, NfL) and cognitive outcomes (general cognition, memory).

Results: Despite significant associations between seven of thirteen risk factors and cognitive outcomes, associations between risk factors and neurodegenerative biomarkers were largely null with some exceptions; for example, hypertension (β=0.17SD; 95% CI:0.08,0.26) and diabetes (β=0.21SD; 95% CI:0.09, 0.32) were associated with higher NfL.

Conclusions: While we found expected associations between lifecourse risk factors for dementia and cognition, there was not strong evidence of cross-sectional associations between risk factors for dementia and plasma-based biomarkers.